Research News and Research

RSS

Scientists discover protein interaction that describes aggressive subtype of medulloblastoma

Scientists at St. Jude Children's Research Hospital and the University of Würzburg in Germany have identified a protein interaction that is a hallmark of an aggressive subtype of medulloblastoma and that may provide a new treatment strategy.

12 Jan 2016

Researchers use quick screening method to identify, test promising anti-Ebola drugs

A quick screening method has been used for the first time in a standard open laboratory to identify and test promising anti-Ebola drugs. This approach increases the possibility of finding new therapies faster.

12 Jan 2016

MD Anderson signs collaborative research and development agreement with Enumeral

The University of Texas MD Anderson Cancer Center today announced that it has entered into a collaborative research and development agreement with Enumeral Biomedical Holdings Inc.

12 Jan 2016

Easy aspiration of small volumes of biological liquid waste

VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.

From INTEGRA Biosciences 11 Jan 2016

McMaster University researchers take a giant leap in detecting early stages of leukemia

McMaster University researchers have taken a giant leap in identifying the early stages of a deadly cancer and predicting how it will develop in individuals.

11 Jan 2016

Cedars-Sinai researcher receives $2.5 million grant to develop risk assessment tool for sudden cardiac arrest

A Cedars-Sinai Heart Institute physician researcher has received a $2.5 million grant from the National Heart, Lung, and Blood Institute to develop a risk assessment tool that could identify patients susceptible to sudden cardiac arrest, a usually fatal heart rhythm malfunction.

11 Jan 2016

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy

A study presented at the 2016 Genitourinary Cancers Symposium shows that 40 percent of patients with castration-resistant metastatic prostate cancer (mCRPC) treated with docetaxel following abiraterone had at least 50 percent reduction in prostate specific antigen (PSA), demonstrating the activity of this drug sequencing.

11 Jan 2016

3 out of 4 young adults with stroke symptoms delay trip to hospital

Up to three hours after a person experiences the first symptom of a stroke is often referred to as the "golden window." That's the period of time doctors say is crucial for patients to get to a hospital to receive medical care in order to restore blood flow to the brain and minimize or reverse damage.

11 Jan 2016

AiCure closes $12.25 million in Series A fundraising round

AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates.

11 Jan 2016

Maxim Healthcare Services earns three 2015 Best Compliance Practice Awards

Maxim Healthcare Services, Inc., a leading provider of home healthcare, medical staffing and population health and wellness services, has been recognized for excellence in compliance and ethics programming by the Health Ethics Trust for the second year in a row.

11 Jan 2016

Bio2 Technologies receives 510(k) clearance from FDA for Fusion Implant system

Bio2 Technologies, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Fusion Implant system for interphalangeal fusion, fracture repair and osteotomies of the toes, fingers and other small bones in the presence of appropriate immobilization.

11 Jan 2016

Sorrento, Karolinska Institutet partner to develop new NK cell-based therapies

Sorrento Therapeutics, Inc., an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, announced today that it has formed an exclusive partnership with the world-renowned Karolinska Institutet in Stockholm, Sweden, to perform cutting-edge immuno-oncology research and to develop new natural killer (NK) cell-based therapies.

11 Jan 2016

Researchers describe three cleaning procedures that effectively remove, disassemble α-Syn fibrils

Lewy bodies and Lewy neurites are found in the brains of Parkinson's disease (PD) patients. They consist primarily of fibrils of the protein alpha-synuclein (α-Syn), which self-assembles into fibrils in vitro. If introduced into the human body, these seeds can act as prions and trigger the formation of toxic protein deposits. Because α-Syn fibrils are often used in research, it is important that they are not accidentally transferred to humans or cell cultures.

11 Jan 2016

NIST chemist develops portable kit for recovering traces of chemical evidence

A chemist at the National Institute of Standards and Technology has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.

11 Jan 2016

Wistar Institute scientists use revolutionary method to block melanoma progression

Melanoma patients who receive treatment with targeted therapies experience an initial response that feels like a cure, but that early excitement is quickly dampened when patients relapse as their cancers find alternative pathways in our cells to grow and spread. With melanoma so good at escaping targeted treatments, there's a dire need to halt these cancers in their tracks to prolong good responses and promote longer, healthier lives.

11 Jan 2016

Genetic factors in puberty timing: an interview with Dr John Perry

The study focused on the genetic regions that influence age at voice breaking - a distinct developmental milestone that happens to young men as their larynx (voice box) lengthens when exposed to male hormones.

11 Jan 2016

Using skin cells to treat injured hearts

Following a heart attack or other heart trauma, the heart is unable to replace its dead cells. Patients are often left with little option other than heart transplants, which are rarely available, or more recently cell therapies that transplant heart cells into the patient's heart. In far too many cases, however, the transplanted heart cells do not engraft well, resulting in poor recovery.

11 Jan 2016

Research News and Research

Scientists discover protein interaction that describes aggressive subtype of medulloblastoma

Researchers use quick screening method to identify, test promising anti-Ebola drugs

MD Anderson signs collaborative research and development agreement with Enumeral

Easy aspiration of small volumes of biological liquid waste

McMaster University researchers take a giant leap in detecting early stages of leukemia

Cedars-Sinai researcher receives $2.5 million grant to develop risk assessment tool for sudden cardiac arrest

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy

3 out of 4 young adults with stroke symptoms delay trip to hospital

AiCure closes $12.25 million in Series A fundraising round

Maxim Healthcare Services earns three 2015 Best Compliance Practice Awards

Bio2 Technologies receives 510(k) clearance from FDA for Fusion Implant system

Sorrento, Karolinska Institutet partner to develop new NK cell-based therapies

Researchers describe three cleaning procedures that effectively remove, disassemble α-Syn fibrils

NIST chemist develops portable kit for recovering traces of chemical evidence

Wistar Institute scientists use revolutionary method to block melanoma progression

Genetic factors in puberty timing: an interview with Dr John Perry

Using skin cells to treat injured hearts

American College of Cardiology to honor LA BioMed researcher with Distinguished Teacher Award

Research could lead to new treatment for Rett Syndrome, other forms of autism

Blocking brain inflammation could protect against memory, behaviour changes

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation